To determine whether AKT2 confers tumor resistance in vivo, tumor xenografts were established by s.c. injection of 5 × 106 L3.6pl, PANC-1, BxPC-3 or MIAPaCa-2 cells into both flanks of 5–6-week-old female athymic nude mice. Here, AKT2 is linked to neoplasm.